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Monoclonal antibodies were raised against prostacyclin synthases purified from bovine and porcine aortae, respectively. Two monoclonal 
antibodies, RSl and RS2, were purihed and characterized. As shown by enzyme activity precipitation and Western blot analysis, in solubilixed bovine 
and porcine aortae microsomes the monoclonal antibodies reacted only with prostacyclin synthase. The monoclonal antibody RSl cross-reacts with 
partially purified prostacyclin synthase from human umbilical veins in an ELISA-based assay. None of the antibodies inhibited the enzyme activity. 
By combination of the monoclonal antibody RS2 with a polyclonal antibody we established an enzyme-linked immunosorbent assay (ELISA) for 
quantitation of bovine prostacyclin synthase. ELISA data were confirmed by Western blot analysis. Among different bovine tissues, aortae with 
1665 f 200 ng/mg microsomal protein showed the highest content of PGIS. Significant lower concentrations were observed in tongue, lung, kidney 
and thymus ranging from 49 + 13.4 to 2.7 f 0.9 ng/mg protein. The monoclonal antibody RSl binds to endothelial cells and vascular smooth muscle 
cells in human liver tissue. 
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1. Introduction 
Prostacyclin is the most potent naturally occurring 
inhibitor of platelet aggregation and also a powerful vas- 
odilator [l]. It is formed by isomerization from the pro- 
staglandin endoperoxide PGH1, catalyzed by the enzyme 
prostacyclin synthase (PGIS), a membrane-bound pro- 
tein associated with the microsomal membranes. Enzy- 
matic activity has been measured in many tissues by 
determination of its stable metabolite 6-keto-PGF,,. The 
enzyme is mainly located in mammalian blood vessels, 
namely in the endothelial and the smooth muscle cells 
[24]. Appreciable PGI, synthetic activity has also been 
reported for a few non-vascular cells including rabbit 
papillary collecting tubule cells [5], human foreskin fi- 
broblasts [6] and bovine corpora lutea [7j. However, the 
cellular sites of PGI, synthesis have not been defined yet. 
Purification to homogeneity of PGIS from bovine and 
porcine aortae has been achieved by our laboratory [8] 
and others [9]. The protein was characterized by us pre- 
viously as a cytochrome P,,,-like enzyme on the basis of 
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Abbreviations: ELISA, enzymelinked immunosorbent assay; PGIS, 
prostacyclin synthase; PG, prostaglandin; HHD, 12-hydroxy-l,lO-hep- 
tadeca-dienoic acid; PBS, phosphate-buffered saline; SDS-PAGE, so- 
dium dodecyl sulfate-polyacrylamide g l electrophoresis. 
its spectroscopic properties [lo]. Recently we succeeded 
in cloning and sequencing the cDNA for bovine PGIS 
1111. 
For localization and quantitation of the enzyme in 
various tissues, the immunochemical approach is ideally 
suited. Although the isolation of monoclonal antibodies 
has been reported [9], only a study on the localization of 
the enzyme among different smooth muscle cells has 
been performed [12], but an assessment of the distribu- 
tion and the enzyme concentration of PGIS in different 
organs is lacking. Furthermore no cross-reactivity to the 
enzyme from human sources is known. In this investiga- 
tion, we describe the generation and characterization of 
monoclonal antibodies directed against purified bovine 
and porcine PGIS and their use in histochemical, West- 
ern blot analysis and immunoquantitation. 
2. Materials and methods 
All culture media, supplements and chemicals were obtained from 
sources as reported earlier [13]. 
2.1. Purification of prostacyclin synthase 
The enzyme was isolated to homogeneity from bovine and porcine 
aortae as described [S]. The tissues were obtained from a local slaughter 
house, human umbilical veins were provided by a nearby hospital. 
2.2. Culture of bovine aortic endothelial cell 
Endothelial cells were isolated from bovine aortae and grown for 5-7 
days in culture flasks as described [20]. The cells were maintained in 
Dulbecco’s mod&d Eagle’s medium (DMEM) containing 10% fetal 
calf serum. Microsomes were prepared from lo7 cells. 
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2.3. Preparation andpuri$cation of polyclonal and monoclonal 
antibodies 
Polyclonal and monoclonal antibodies directed to purified PGIS 
from bovine and porcine aortae were prepared according to a similar 
scheme reported recently [13]. Large amounts of monoclonal antibodies 
were produced by culturing hybridoma cells in roller bottles. The anti- 
bodies were purified from culture supernatants by protein G immu- 
noaftinity chromatography according to the instruction of the supplier 
and stored at a concentration of 2 mg/ml at -20°C. 
2.4. ELISA 
The reactivity of hybridoma culture supernatants was assessed by 
ELISA. Purified PGIS from bovine or porcine aortae (50 rig/well) were 
adsorbed to microtiter plates. Residual bindina sites in the wells were 
blocked by 0.5% gelatin in PBS. After washing, plates were incubated 
with hybridoma supernatants and incubated for 1 h. The wells were 
washed again and incubated for 1 h with peroxidase-labeled goat anti- 
mouse IgG. Peroxidase reaction was initiated by the addition of phen- 
ylenediamine (1 mg/ml) and 0.01% H,O, and maintained for 15 min at 
37°C and read at 492 nm. By this procedure several hybridoma cell lines 
producing anti-PGIS antibodies were obtained. Two clones were se- 
lected for further characterization. 
For analysis of cross-reactivity, 200 ng/ml of partially purified en- 
zyme (after the DEAE-purification step) from bovine and porcine aor- 
tae and from human umbilical veins were used (specific activities: 215, 
44, and 3.8 nmol/mg/min, respectively). 
2.5. Western blot 
Western blot analyses were performed as described in a recent paper 
[14] except that the enhanced cherniluminescence-technique wasused 
for visualization. 
2.6. Measurement of enzyme activity 
Enzymatic activity of PGIS was determined by the conversion of 
PGH, to HHD, as described by us recently [15,16]. Briefly, enzyme 
samples were diluted in 500 ,~l reaction buffer (10 mM KJIPG~, 20% 
glycerol, 1 mM EDTA, 0.2% Lubrol PX, pH 7.5) and the reaction was 
started by the addition of 14 ,uM PGH,. The formation of HHD was 
monitored at 233 mn and from the initial slopes enzyme activities were 
calculated 
2.7. Immunoprecipitation 
For precipitation of PGIS by monoclonal antibodies, enzyme sam- 
ples from porcine and bovine aortae after the DEAE purification step 
were used. 50 ~1 of various dilutions of monoclonal antibodies, pre- 
bound overnight o protein G-Sepharose, was incubated with 100 ,~l of 
enzyme sample (specific activity: 215 and 44 mnol/mg/min for bovine 
and porcine PGIS) for 2 h on ice. The reaction tubes were centrifuged 
at 10,000 x g and the remaining enzyme activity was measured in the 
supernatant. 
2.8. IgG subclass determination 
The subclasses of the monoclonal antibodies were determined as 
described in [13]. 
2.9. Immunohistochemistry 
Liver tissue was shock-frozen at -100°C and frozen sections were 
layered onto microscope slides, fixed by acetone for 10 min at room 
temperature and incubated with purified RSl monoclonal antibody in 
a dilution of 1:lOO. The sections were washed twice and stained with 
fluorescein-labeled goat anti-mouse IgG, diluted 1:20. The sections 
were viewed using band pass filter selective for green fluorescence. As 
a negative control, the monoclonal antibody RSl was omitted. 
2.10. Immunoquantitation f PGIS 
For immunoenzymometry, pm&d polyclonal antibodies were di- 
luted in 50 mM NaHCO,, pH 8.3, and coated onto microtiter plates for 
1 h at room temperature in a humid chamber. Free binding sites were 
blocked by washing the plates twice for 30 mm with 0.5% BSA. Solubil- 
ized microsomes (200 ,&well) or purilied bovine PGIS as standard 
were added and incubated for a 1 h at room temperature. After wash- 
ing, assays were incubated with purified monoclonal antibody RS2 
(1: 10.000 dilution) for 1 h. Visualization of the enzyme was 
performed as described in section 2.4. 
3. Results 
For raising monoclonal antibodies, purified PGIS 
from bovine and porcine tissues were injected into mice 
and were also used for screening of the hybridoma mi- 
crocultures. Several genetically stable clones were ob- 
tained. Two of them were selected for further studies. 
RSl directed against porcine PGIS and RS2 with speci- 
ficity towards bovine PGIS. Both antibodies belong to 
the IgG, subclass. Large scale production was performed 
by cell culture and antibodies were subsequently purified 
by protein G-Sepharose chromatography (data not 
shown). 
Their binding specificity is demonstrated in Fig. 1 as 
revealed by the ELISA technique. Serial dilutions of the 
monoclonal antibodies show concentration-dependent 
binding to the partially purified enzymes including 
saturability of the antigens’ epitopes. RS2 raised against 
bovine PGIS, also possesses cross-reactivity towards 
porcine PGIS. However, no cross-reactivity was ob- 
served for RSl towards bovine PGIS (data not shown). 
To address this phenomenon regarding human PGIS, 
partially purified enzyme from umbilical veins was 
monitored for epitope binding according to the same 
technique. As shown in Fig. 1, RSl but not RS2 is cross- 
reactive towards human PGIS. To characterize the mon- 
oclonal antibodies under more stringent, i.e. denaturing 
conditions, the antibodies were examined using the im- 
munoblot technique. Partially purified bovine and por- 
cine protein samples. were subjected to SDS-PAGE, 
transferred to nitrocellulose paper, and assayed for anti- 
body staining (Fig. 2). As a control, an anti-PGIS anti- 
serum was used. RS2 showed a single band at 52 kDa, 
corresponding to PGIS and excluding any other im- 
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Fig. 1. Assessment of the binding capacity of the monoclonal antibodies 
RSl and RS2 to partially purified PGIS from bovine and porcine aortae 
and from human umbilical veins. The microtiter plates were coated with 
200 ng of enzyme sample. Starting from a 2 mg/ml stock solution the 
antibodies were used in the indicated manner Triangle = monoclonal 
antibody RS 1; closed = porcine PGIS; open = human PGIS. 
Square = monoclonal antibody RS2; closed = bovine PGIS; 
open = human PGIS. 
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Fig. 2. Western blots of bovine and porcine solubilized microsomes 
probed with monoclonal and polyclonal antibodies to PGIS. DEAE- 
purified enzyme samples (80 pg/lane) from bovine (lane 1 and 2) and 
porcine aortae (lane 3 and 4), respectively, was run on 10% SDS-gels 
and transferred to nitrocelhtlose. Immunoblotting was performed es- 
sentially as described in [14]. Lane 1 and 3 = probed with polyclonal 
antibody; lane 2 = monoclonal antibody RS2; lane 4 = monoclonal 
antibody RS 1. 
munoreactive protein. In accordance with the results 
above monoclonal antibody RSl is not reactive towards 
bovine PGIS after gel electrophoresis nitrocellulose 
transfer. 
The monoclonal antibodies’ specificity for PGIS was 
further evaluated in an immunoprecipitation assay using 
protein G-Sepharose for pelleting the PGIS-antibody 
complex. Fig. 3 demonstrates the increase of the precip- 
itated activity as a consequence of increasing concentra- 
tions of both monoclonal antibodies. A control antibody 
(Tti300, a monoclonal antibody directed to thromboxane 
synthase [I 31) could not substitute for RSl and RS2. 
When protein G-Sepharose was omitted, no loss of activ- 
ity was found, indicating that the monoclonal antibodies 
did not react with the active site of the enzymes (data not 
shown). 
For immunoquantitation of PGIS we established a 
sandwich-ELISA, as we did recently for thromboxane 
synthase [17]. As shown in Fig. 4, the absorbance at 492 
Table 1 
Determination of PGIS amount by different spectroscopy with tranyl- 
cypromine and ELISA-based immunoenxymometry 
Method Enzyme content Specific activity 
@g PGIS/mg protein) (nmol PGIJmin/mg) 
Spectroscopy with 
tranylcypromine* 
ELISA 
94 1302.4 
42 + 3.8 1302.4 
PGIS enzyme preparation after the DEAE puritication step was used 
in parallel and the enzyme content was determined as described in 
section 2. 
*trans-2-Phenylcyclopropylamine E435_,,4 nm = 28 mM_’ . cm-‘. 
nm after log transformation was linear in the range from 
20 to 800 ng. The versatility of the ELISA-based immu- 
noquantitation was verified by difference spectroscopy 
of DEAE-purified PGIS (Table 1). Although these are 
completely different techniques, both methods revealed 
a similar enzyme determination. 
The quantity of PGIS in different bovine tissues as 
calculated by the sandwich-ELISA technique is given in 
Table 2. A heterogenous distribution of enzyme was ob- 
served. The highest content of 1665 + 200 ng/mg micro- 
somal protein was found in the aortae. Much lower 
amounts of enzyme are present in tongue and lung, 
whereas it is barely detectable in kidney and thymus. 
Compared with microsomes from cultured bovine endo- 
thelial cells fresh bovine aortae have a nearly lo-fold 
higher content of PGIS. The specific activities of PGIS 
in the different tissues correlate well with the determined 
enzyme levels (Table 2). 
To conturn the immunoquantitation data by Western 
blot, solubilized tissue microsomes (70 ,ug each and 
20 pg for aorta) were subjected to SDS-PAGE followed 
by immunoblot analysis. As outlined in Fig. 5 the rela- 
tive intensities of the band corresponding to purified bo- 
vine PGIS (lane 1) correlate well with the data listed in 
Table 2. 
To demonstrate the usefulness of RSl for immunohis- 
tochemical analyses of human tissues, monoclonal anti- 
body RSl, which shows cross-reactivity to native PGIS 
from human umbilical veins, was tested on cryostat sec- 
tions of human liver by immunofluorescence t chnique. 
As shown in Fig. 6, PGIS can specifically be localized in 
sinusoidal endothelial cells and smooth muscle cells of 
blood vessels. In contrast hepatocytes and Kupffer cells 
are devoid of staining. The photograph does-not une- 
quivally show the absence of PGIS from Kupffer cells 
or .“” ,,,‘,I 
1 10 100 
antibody dilution 
Fig. 3. Immunoprecipitation of PGIS activity by monoclonal antibod- 
ies RSl and RS2. The assays contained partially purified enzyme from 
bovine or porcine aortae and monoclonal antibodies bound to protein 
G-Sepharose and diluted as indicated. Enzyme activities were measured 
in the remaining supematant after pelleting the antibody-protein 
G-Sepharose-enxyme complex. Open circle = monoclonal antibody 
RSl; closed square = monoclonal antibody RS2. 
224 I. Siegle et al. IFEBS Letters 347 (1994) 221-225 
ng BOVINE PROSTACYCLIN SYNTHASE 
Fig. 4. ELISA standard curve for bovine PGIS. Various amounts of 
purified bovine PGIS were subjected to the enzyme immunoassay (cir- 
cles); log transformation and linear regression (triangles). Assays were 
performed as described in section 2. 
although available enzymological data support this as- 
sumption. 
4. Discussion 
The purified heme-thiolate nzyme prostacyclin syn- 
thase from bovine and porcine aortae were successfully 
used for the preparation of polyclonal and monoclonal 
antibodies. The specificities of the monoclonal antibody 
RSl, directed to porcine and RS2, directed to bovine 
PGIS, were demonstrated by different techniques, such 
as ELISA, immunoblot analysis and precipitation of 
PGIS activity. As neither the polyclonal nor the mono- 
clonal antibodies inhibited the enzyme activity, we sug- 
gest that the active site is not affected and probably 
protected by a pocket form. The epitope for RSl seems 
to be a conformational determinant, since it was de- 
stroyed by electrophoresis. In contrast, RS2 reacts with 
an epitope which is uneffected by denaturing agents. 
Table 2 
Immunoenzymometric assessment ofprostacyclin synthase content and 
specific activity in solubilized microsomes of different bovine tissues 
Tissue Enzyme content Specific activity 
(ng PGWmg protein) (mnol PGI,/min/mg) 
Tongue 49 k 13.4 0.8 
Lung 28 + 4.1 0.7 
Liver 14.3 k 2.1 0.35 
Thymus 2.7 + 0.9 0.16 
Endothelial cells 127.6 f 48 1.2 
Aorta 1665 f 200 13.2 
Kidney 8.5 f 1.9 0.47 
Both parameters were determined as described in ‘Materials and Meth- 
ods’. The data are mean values of 4 experiments + S.D. 
One of the most promising applications of the anti- 
bodies will be for immunohistochemistry. The data dem- 
onstrate that monoclonal antibody RSl cross-reacts with 
the enzyme partially purified from human umbilical 
veins and stains endothelial and smooth muscle cells in 
human liver sections. This finding agrees with reports on 
the capacity of these cells to synthesize prostacyclin. 
A sandwich-ELISA has been developped and success- 
fully applied in quantitating PGIS levels of different bo- 
vine tissues. Compared to an immunoradiometric assay 
[ 181, this method has the advantage to circumvent radio- 
active labeling without substantial loss of simplicity and 
sensitivity. Here we report for the fist time on the PGIS 
enzyme content in different tissues and correlate its 
amount with the specific activities. The high quantity of 
enzyme found in aorta tissue underlines the important 
function of PGI, for hemostasis. However, compared to 
the aorta tissue the PGIS content in cultured bovine 
endothelial cells is one order of magnitude lower. These 
findings are in contrast to data reflecting similar 
amounts of PGIS in endothelial and smooth muscle ceils 
[19]. Our results would explain the low levels of PGIS 
found in other tissues with a much lower portion of 
smooth muscle cells. But, because we measured enzyme 
content and activity in microsomal preparations, enzyme 
present in other compartments or being solubilized dur- 
ing microsome preparation could escape detection. For 
some types of smooth muscle cells an immunocytochem- 
ical study [12] reported on the association of PGIS with 
the cell surface and the nuclear membrane, indicating at 
least two separate membrane systems. 
In view of the important role of prostacyclin especially 
as a physiological antagonist of thromboxane A,, further 
cellular and subcellular localization and quantitation of 
PGIS will be a subject of future investigations. In this 
context the characterized monoclonal antibodies will be 
valuable tools. 
MW 
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Fig. 5. Immunoblot analysis of solubilixed microsomes from different 
bovine tissues. Solubilixed microsomes (70 pug each, 20 pug for aorta) 
were separated by SDS-PAGE and transferred to nitrocellulose paper. 
Lane 1 = control; lane 2 = tongue.; lane 3 = lung; lane 4 = liver; lane 
5 = thymus; lane 6 = bovine endothelial cells; lane 7 = bovine aorta; 
lane 8 = kidney. Blotting was performed as described in section 2. As 
control 200 ng of purified bovine PGIS was used. 
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Fig. 6. Photomicrograph of a cryostat section of human liver incubated 
with monoclonal antibody RSl. Immunoreactivity was visualized with 
fluoresce&labeled anti-mouse IgG, antibodies as described in section 
2. Magnification: 27 x . 
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